New Zealand markets closed

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5871-0.0079 (-0.50%)
As of 02:48PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 108.37M
Enterprise value 25.29M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)242.22
Price/book (mrq)1.20
Enterprise value/revenue 71.66
Enterprise value/EBITDA -0.48

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-18.21%
S&P500 52-week change 321.08%
52-week high 32.7000
52-week low 31.0800
50-day moving average 31.8102
200-day moving average 31.6206

Share statistics

Avg vol (3-month) 3559.86k
Avg vol (10-day) 3301.69k
Shares outstanding 567.94M
Implied shares outstanding 668.15M
Float 860.12M
% held by insiders 12.62%
% held by institutions 161.90%
Shares short (15 Apr 2024) 4383.05k
Short ratio (15 Apr 2024) 40.71
Short % of float (15 Apr 2024) 40.80%
Short % of shares outstanding (15 Apr 2024) 40.56%
Shares short (prior month 15 Mar 2024) 4289.27k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 Jul 2019
Ex-dividend date 4N/A
Last split factor 21:14
Last split date 301 Jul 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-15,557.79%

Management effectiveness

Return on assets (ttm)-31.72%
Return on equity (ttm)-62.31%

Income statement

Revenue (ttm)353k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -54.33M
Net income avi to common (ttm)-50.39M
Diluted EPS (ttm)-0.9400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)98.17M
Total cash per share (mrq)1.45
Total debt (mrq)15.1M
Total debt/equity (mrq)16.69%
Current ratio (mrq)6.27
Book value per share (mrq)1.43

Cash flow statement

Operating cash flow (ttm)-33.22M
Levered free cash flow (ttm)-21.18M